Liposomal Formulations of Novel BODIPY Dimers as Promising Photosensitizers for Antibacterial and Anticancer Treatment
Molecules · 2024
DOI: 10.3390/molecules29225304 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, 2024. Verfasst von Weronika Porolnik und 5 weiteren Autor:innen. Beteiligte Einrichtung: Chair and Department of Inorganic and Analytical Chemistry, Poznan University of Medical Sciences, Rokietnicka 3, 60-806 Poznan, Poland. Hauptthemen laut MEDLINE: Liposomes, Photosensitizing Agents, Boron Compounds, Anti-Bacterial Agents. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 86 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Science Center, National Science Center, Poland.
Abstract (Originalsprache)
Synthesis, photochemical properties, liposomal encapsulation, and in vitro photodynamic activity studies of novel BODIPY dimer connected at meso-meso positions and its brominated and iodinated analogs were described. UV-Vis measurements indicated that the dimeric structure of obtained BODIPYs did not significantly influence the positions of the absorption maxima. Emission properties and singlet oxygen generation studies revealed a strong heavy atom effect of brominated and iodinated BODIPY dimers, manifested by fluorescence intensity reduction and increased singlet oxygen generation ability compared to analog without halogen atoms. For the in vitro photodynamic activity studies, dimers were incorporated into two different types of liposomes: positively charged DOTAP:POPC and negatively charged POPG:POPC. The photoinactivation studies revealed high activity of brominated and iodinated dimers incorporated into DOTAP:POPC liposomes on both Gram-positive Staphylococcus aureus and Gram-negative Escherichia coli. Anticancer studies on human breast adenocarcinoma MDA-MB-231 and human ovarian carcinoma A2780 cells revealed that DOTAP:POPC liposomes containing brominated and iodinated dimers were active even at low nanomolar concentrations. In addition, they were more active against MDA-MB-231 cells than A2780 cells, which is particularly important since the MDA-MB-231 cell line represents triple-negative breast cancer, which has limited therapeutic options.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Chair and Department of Inorganic and Analytical Chemistry, Poznan University of Medical Sciences, Rokietnicka 3, 60-806 Poznan, Poland.
- Chair and Department of Toxicology, Poznan University of Medical Sciences, Rokietnicka 3, 60-806 Poznan, Poland.
- Doctoral School, Poznan University of Medical Sciences, Bukowska 70, 60-812 Poznan, Poland.
- Chair and Department of Genetics and Pharmaceutical Microbiology, Poznan University of Medical Sciences, Rokietnicka 3, 60-806 Poznan, Poland.
ORCID-Profile: Marek Murias, Malgorzata Kucinska, Jaroslaw Piskorz
Förderung
- National Science Center
- National Science Center, Poland
Zitieren
APA
Porolnik, W., Ratajczak, M., Mackowiak, A., Murias, M., Kucinska, M., & Piskorz, J. (2024). Liposomal Formulations of Novel BODIPY Dimers as Promising Photosensitizers for Antibacterial and Anticancer Treatment. Molecules. https://doi.org/10.3390/molecules29225304
Vancouver
Porolnik W, Ratajczak M, Mackowiak A, Murias M, Kucinska M, Piskorz J. Liposomal Formulations of Novel BODIPY Dimers as Promising Photosensitizers for Antibacterial and Anticancer Treatment. Molecules. 2024. doi:10.3390/molecules29225304
BibTeX
@article{Porolnik2024,
author = {Porolnik, Weronika and Ratajczak, Magdalena and Mackowiak, Aleksandra and Murias, Marek and Kucinska, Malgorzata and Piskorz, Jaroslaw},
title = {Liposomal Formulations of Novel BODIPY Dimers as Promising Photosensitizers for Antibacterial and Anticancer Treatment},
journal = {Molecules},
year = {2024},
doi = {10.3390/molecules29225304}
}
EUVIMED